Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 3/2011

01.05.2011 | Original Article

Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children

verfasst von: Jerzy Konstantynowicz, Dariusz M. Lebensztejn, Elzbieta Skiba, Maria E. Sobaniec-Lotowska, Pawel Abramowicz, Janina Piotrowska-Jastrzebska, Maciej Kaczmarski

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Chronic liver disease in adults is a risk factor of osteoporosis, but little is known about risk of fractures in children with non-cholestatic liver disease. The aim of this study was to investigate associations among the severity of liver fibrosis, bone mass and low-energy fractures in children. History of fractures, anthropometry, and bone mass and size were examined in 39 Caucasian children (25 boys, 14 girls) aged 7.1–18 years (mean 11.9 ± 3.1) with chronic hepatitis B and liver fibrosis evidenced by liver biopsy. Severity of liver fibrosis was based on histological classification according to the method of Batts and Ludwig (mild, 1–2 scores; advanced, 3 scores) and Ishak (1–3 and 4–5 scores, respectively). Bone mineral content (BMC), density (BMD) and body composition were determined in the total body and lumbar spine using dual energy X-ray absorptiometry. Seven subjects (4 girls, 3 boys; 18% of the sample) had low BMD in the total body and lumbar spine region (Z-scores below −2.0). No associations were found among BMC, BMD, bone size and the severity of liver fibrosis. Nine boys (36% of all boys) and one girl reported repeated fractures (forearm, wrist, tibia, ankle, humerus), showing trends similar to the prevalence in general population. Fractures were neither associated with lower BMD/BMC nor with scores of liver fibrosis. Deficits in BMD in children with chronic hepatitis B are not associated with the severity of liver fibrosis. This study suggests that non-cholestatic liver disease does not increase the risk of low-energy fractures during growth. From the practical perspective, however, children with chronic liver disease should be screened for history and clinical risk factors for fractures rather than referred to bone density testing.
Literatur
1.
Zurück zum Zitat Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D (1998) Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28:695–699PubMedCrossRef Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D (1998) Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28:695–699PubMedCrossRef
2.
Zurück zum Zitat Masaki K, Shiomi S, Kuroki T, Tanaka T, Monna T, Ochi H (1998) Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver. J Gastroenterol 33:236–240PubMedCrossRef Masaki K, Shiomi S, Kuroki T, Tanaka T, Monna T, Ochi H (1998) Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver. J Gastroenterol 33:236–240PubMedCrossRef
3.
Zurück zum Zitat Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH (2004) Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 10:648–653PubMedCrossRef Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH (2004) Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 10:648–653PubMedCrossRef
4.
Zurück zum Zitat Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG (2004) Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89:4325–4330PubMedCrossRef Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG (2004) Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89:4325–4330PubMedCrossRef
5.
Zurück zum Zitat Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR (1990) Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 12:273–280PubMedCrossRef Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR (1990) Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 12:273–280PubMedCrossRef
6.
Zurück zum Zitat Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ (2000) Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118:145–151PubMedCrossRef Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ (2000) Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118:145–151PubMedCrossRef
7.
Zurück zum Zitat Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390PubMedCrossRef Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390PubMedCrossRef
8.
Zurück zum Zitat Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49:282–287PubMedCrossRef Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49:282–287PubMedCrossRef
9.
Zurück zum Zitat Hirano Y, Kishimoto H, Hagino H, Teshima R (1999) The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab 17:119–124PubMedCrossRef Hirano Y, Kishimoto H, Hagino H, Teshima R (1999) The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab 17:119–124PubMedCrossRef
10.
Zurück zum Zitat Olsson R, Johansson C, Lindstedt G, Mellstrom D (1994) Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 29:753–756PubMedCrossRef Olsson R, Johansson C, Lindstedt G, Mellstrom D (1994) Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 29:753–756PubMedCrossRef
11.
Zurück zum Zitat Isaia G, Di Stefano M, Roggia C, Ardissone P, Rosina F (1998) Bone disorders in cholestatic liver diseases. Forum (Genova) 8:28–38 Isaia G, Di Stefano M, Roggia C, Ardissone P, Rosina F (1998) Bone disorders in cholestatic liver diseases. Forum (Genova) 8:28–38
12.
Zurück zum Zitat Sylvester FA (1999) Bone abnormalities in gastrointestinal and hepatic disease. Curr Opin Pediatr 11:402–407PubMedCrossRef Sylvester FA (1999) Bone abnormalities in gastrointestinal and hepatic disease. Curr Opin Pediatr 11:402–407PubMedCrossRef
13.
Zurück zum Zitat Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G (2003) Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res 54:125–136PubMedCrossRef Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G (2003) Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res 54:125–136PubMedCrossRef
14.
Zurück zum Zitat Tanner JM (1978) Physical growth and development. In: Forfar J, Arnell CC (eds) Textbook of pediatrics, 2nd edn. Edinbourgh, Scotland, pp 249–303 Tanner JM (1978) Physical growth and development. In: Forfar J, Arnell CC (eds) Textbook of pediatrics, 2nd edn. Edinbourgh, Scotland, pp 249–303
15.
Zurück zum Zitat Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417PubMedCrossRef Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417PubMedCrossRef
16.
Zurück zum Zitat Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699PubMedCrossRef Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699PubMedCrossRef
17.
Zurück zum Zitat Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the international society for clinical densitometry and executive summary of the 2007 ISCD pediatric position development conference. J Clin Densitom 11:6–21PubMedCrossRef Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the international society for clinical densitometry and executive summary of the 2007 ISCD pediatric position development conference. J Clin Densitom 11:6–21PubMedCrossRef
18.
Zurück zum Zitat Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballeria L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodes J (2001) Collagen type I alpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 33:554–560PubMedCrossRef Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballeria L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodes J (2001) Collagen type I alpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 33:554–560PubMedCrossRef
19.
Zurück zum Zitat Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, d Oliveira M, Lamy RA, Oliveira DS (2001) Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16:1022–1027PubMedCrossRef Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, d Oliveira M, Lamy RA, Oliveira DS (2001) Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16:1022–1027PubMedCrossRef
20.
Zurück zum Zitat Crawford BA, Kam C, Donaghy AJ, McCaughan GW (2003) The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14:987–994PubMedCrossRef Crawford BA, Kam C, Donaghy AJ, McCaughan GW (2003) The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14:987–994PubMedCrossRef
21.
Zurück zum Zitat Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M (2000) Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 45:1392–1399PubMedCrossRef Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M (2000) Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 45:1392–1399PubMedCrossRef
22.
Zurück zum Zitat Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847PubMed Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847PubMed
23.
Zurück zum Zitat Gur A, Dikici B, Nas K, Bosnak M, Haspolat K, Sarac AJ (2005) Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent osteoporosis? BMC Gastroenterol 5:30PubMedCrossRef Gur A, Dikici B, Nas K, Bosnak M, Haspolat K, Sarac AJ (2005) Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent osteoporosis? BMC Gastroenterol 5:30PubMedCrossRef
24.
Zurück zum Zitat Ma DQ, Jones G (2002) Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 38:497–500PubMedCrossRef Ma DQ, Jones G (2002) Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 38:497–500PubMedCrossRef
25.
26.
Zurück zum Zitat Khosla S, Melton LJ 3rd, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL (2003) Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 290:1479–1485PubMedCrossRef Khosla S, Melton LJ 3rd, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL (2003) Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 290:1479–1485PubMedCrossRef
27.
Zurück zum Zitat Lyons RA, Delahunty AM, Kraus D, Heaven M, McCabe M, Allen H, Nash P (1999) Children’s fractures: a population based study. Inj Prev 5:129–132PubMedCrossRef Lyons RA, Delahunty AM, Kraus D, Heaven M, McCabe M, Allen H, Nash P (1999) Children’s fractures: a population based study. Inj Prev 5:129–132PubMedCrossRef
28.
Zurück zum Zitat Jones IE, Cannan R, Goulding A (2000) Distal forearm fractures in New Zealand children: annual rates in a geographically defined area. N Z Med J 113:443–445PubMed Jones IE, Cannan R, Goulding A (2000) Distal forearm fractures in New Zealand children: annual rates in a geographically defined area. N Z Med J 113:443–445PubMed
29.
Zurück zum Zitat Hagino H, Yamamoto K, Ohshiro H, Nose T (2000) Increasing incidence of distal radius fractures in Japanese children and adolescents. J Orthop Sci 5:356–360PubMedCrossRef Hagino H, Yamamoto K, Ohshiro H, Nose T (2000) Increasing incidence of distal radius fractures in Japanese children and adolescents. J Orthop Sci 5:356–360PubMedCrossRef
30.
Zurück zum Zitat Jones IE, Williams SM, Dow N, Goulding A (2002) How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development study. Osteoporos Int 13:990–995PubMedCrossRef Jones IE, Williams SM, Dow N, Goulding A (2002) How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development study. Osteoporos Int 13:990–995PubMedCrossRef
31.
Zurück zum Zitat Brudvik C, Hove LM (2003) Childhood fractures in Bergen, Norway: identifying high-risk groups and activities. J Pediatr Orthop 23:629–634PubMedCrossRef Brudvik C, Hove LM (2003) Childhood fractures in Bergen, Norway: identifying high-risk groups and activities. J Pediatr Orthop 23:629–634PubMedCrossRef
32.
Zurück zum Zitat Konstantynowicz J, Bialokoz-Kalinowska I, Motkowski R, Abramowicz P, Piotrowska-Jastrzebska J, Sienkiewicz J, Seeman E (2005) The characteristics of fractures in Polish adolescents aged 16–20 years. Osteoporos Int 16:1397–1403PubMedCrossRef Konstantynowicz J, Bialokoz-Kalinowska I, Motkowski R, Abramowicz P, Piotrowska-Jastrzebska J, Sienkiewicz J, Seeman E (2005) The characteristics of fractures in Polish adolescents aged 16–20 years. Osteoporos Int 16:1397–1403PubMedCrossRef
33.
Zurück zum Zitat Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ (2001) Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy X-ray absorptiometry study. J Pediatr 139:509–515PubMedCrossRef Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ (2001) Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy X-ray absorptiometry study. J Pediatr 139:509–515PubMedCrossRef
34.
Zurück zum Zitat Ma D, Jones G (2004) Soft drink and milk consumption, physical activity, bone mass, and upper limb fractures in children: a population-based case-control study. Calcif Tissue Int 75:286–291PubMedCrossRef Ma D, Jones G (2004) Soft drink and milk consumption, physical activity, bone mass, and upper limb fractures in children: a population-based case-control study. Calcif Tissue Int 75:286–291PubMedCrossRef
35.
Zurück zum Zitat Ma D, Morley R, Jones G (2004) Risk-taking, coordination and upper limb fractures in children: a population based case–control study. Osteoporos Int 15:633–638PubMedCrossRef Ma D, Morley R, Jones G (2004) Risk-taking, coordination and upper limb fractures in children: a population based case–control study. Osteoporos Int 15:633–638PubMedCrossRef
36.
Zurück zum Zitat Tsuneoka K, Tameda Y, Takase K, Nakano T (1996) Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 31:669–678PubMedCrossRef Tsuneoka K, Tameda Y, Takase K, Nakano T (1996) Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 31:669–678PubMedCrossRef
37.
Zurück zum Zitat George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N (2009) Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 28:3516–3522CrossRef George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N (2009) Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 28:3516–3522CrossRef
Metadaten
Titel
Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children
verfasst von
Jerzy Konstantynowicz
Dariusz M. Lebensztejn
Elzbieta Skiba
Maria E. Sobaniec-Lotowska
Pawel Abramowicz
Janina Piotrowska-Jastrzebska
Maciej Kaczmarski
Publikationsdatum
01.05.2011
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 3/2011
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-010-0219-7

Weitere Artikel der Ausgabe 3/2011

Journal of Bone and Mineral Metabolism 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.